ESC 365 - ANDAMAN - Aspirin twice a day and Acute Coronary Syndrome

ESC2025 Premium Access

ANDAMAN - Aspirin twice a day and Acute Coronary Syndrome

Session: Late-Breaking Clinical Trials: cardiovascular risk and prevention

Topic: Pharmacotherapy

Speaker: Professor J. Dillinger (Paris, FR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Jean-Guillaume Dillinger

Hospital Lariboisiere, Paris (France)

2 presentations

0 follower

3 more presentations in this session

Biomarker-guided risk management following acute coronary syndromes

Speaker: Professor R. Doughty (Auckland, NZ)

CAC CV-PREVITAL Coronary Artery Calcium Scoring in primary prevention

Speaker: Doctor G. Ferrante (Milan, IT)

CONFIDENCE: ambulatory blood pressure monitor substudy

Speaker: Doctor M. Vaduganathan (Boston, US)

Access the full session

Late-Breaking Clinical Trials: cardiovascular risk and prevention

Speakers: Professor J. Dillinger, Professor R. Doughty, Doctor G. Ferrante, Doctor M. Vaduganathan

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources